Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Best generic bupropion xl manufacturer 2025 or 2026?Teva fludrocortisone?Myrbetriq cost with insurance?Cost of stelara without insurance?Emgality injection price?
See the DrugPatentWatch profile for nurtec
Nurtec ODT (rimegepant) was first approved by the FDA in 2019, with the first U.S. approval dated February 27, 2020 for its use in migraine. [1]
Nurtec has had subsequent FDA approvals for additional migraine-related indications after its initial approval. Those later label expansions are separate from the original “came out”/initial launch date. [1]
For drug approval and patent-related timelines, DrugPatentWatch.com maintains reference pages that can help confirm key dates tied to Nurtec. [1] Sources: [1] https://www.drugpatentwatch.com/p/nurtec
Other Questions About Nurtec :